The Journal of Emergency Medicine
Volume 32, Issue 1 , Pages 27-39 , January 2007

Treatment strategies for reducing asthma-related emergency department visits

  • Joseph P. Ornato, MD, FACC, FACP, FACEP

      Affiliations

    • Corresponding Author InformationReprint Address: Joseph P. Ornato, md, Department of Emergency Medicine, Virginia Commonwealth University Medical Center, 1250 East Marshall Street, PO Box 980401, Richmond, VA 23298-0401

Received 2 February 2005 ,Revised 4 August 2005 ,Accepted 7 April 2006.

References 

  1. Centers for Disease Control and Prevention. Asthma prevalence, health care use and mortality, 2002. Available at: www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm. Accessed May 16, 2005.
  2. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults. Chest. 2004;125:1081–1102
  3. Pollack CV, Pollack ES, Baren JM, et al. A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute asthma. Arch Pediatr Adolesc Med. 2002;156:934–940
  4. Weber EJ, Silverman RA, Callaham ML, et al. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med. 2002;113:371–378
  5. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis (I. Assessing the economic impact). J Allergy Clin Immunol. 2001;107:3–8
  6. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997;156:787–793
  7. Lozano P, Sullivan SD, Smith DH, Weiss KB. Asthma, rhinitis, other respiratory diseases (The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey). J Allergy Clin Immunol. 1999;104:957–963
  8. Barnes PJ. The size of the problem of managing asthma. Respir Med. 2004;98(Suppl B):S4–S8
  9. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802–807
  10. Stempel DA, Roberts CS, Standford RH. Treatment patterns in the months prior to and after asthma-related emergency department visit. Chest. 2004;126:75–80
  11. Smith MJ, Rascati KL, McWilliams BC. Inhaled anti-inflammatory pharmacotherapy and subsequent emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol. 2004;92:40–46
  12. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma.Bethesda, MD: National Institutes of Health, April 1997; NIH Publication No. 97-4051.
  13. National Asthma Education and Prevention Program. Update on Selected Topics 2002. Bethesda, MD: National Institutes of Health, June 2003; NIH Publication No. 02-5074.
  14. Rodrigo GJ, Rodrigo C. Continuous vs intermittent b-agonists in the treatment of acute adult asthma (A systematic review with meta-analysis). Chest. 2002;122:160–165
  15. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a meta-analysis of randomized clinical trials. Ann Emerg Med. 1999;34:8–18
  16. Rodrigo GJ, Verde MR, Peregalli V, Rodrigo C. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma (A randomized trial). Chest. 2003;124:1312–1317
  17. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev. 2001;1:CD000195
  18. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma (An evidence-based evaluation). Chest. 1999;116:285–295
  19. McCarren M, Zalenski RJ, McDermott M, Kaur K. Predicting recovery from acute asthma in an emergency diagnostic and treatment unit. Acad Emerg Med. 2000;7:28–35
  20. Reuben AD, Harris AR. Heliox for asthma in the emergency department: a review of the literature. Emerg Med J. 2004;21:131–135
  21. Ho AM, Lee A, Karmakar MK, Dion PW, Chung DC, Contardi LH. Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma: a systematic overview. Chest. 2003;123:882–890
  22. Kaye P, O’Sullivan I. The role of magnesium in the emergency department. Emerg Med J. 2002;19:288–291
  23. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA. Intravenous magnesium sulfate for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med. 2000;36:181–190
  24. Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child. 2005;90:74–77
  25. Camargo CA, Smithline HA, Malice M-P, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003;167:528–533
  26. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest. 2004;126:1480–1489
  27. Edmonds ML, Camargo CA, Pollack CV, Rowe BH. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med. 2002;40:145–154
  28. Emerman CL, Woodruff PG, Cydulka RK, et al. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. Chest. 1999;115:919–927
  29. Emerman CL, Cydulka RK, Crain EF, Rowe BH, Radeos MS, Camargo CA. Prospective multicenter study of relapse after treatment for acute asthma among children presenting to the emergency department. J Pediatr. 2001;138:318–324
  30. Krishnan JA, Riekert KA, McCoy JV, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004;170:1281–1285
  31. Schuckman H, DeJulius DP, Blanda M, Gerson LW, DeJulius AJ, Rajaratnam M. Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: A randomized controlled trial. Ann Emerg Med. 1998;31:333–338
  32. Lahn M, Bijur P, Gallagher EJ. Randomized clinical trial of intramuscular vs oral methylprednisolone in the treatment of asthma exacerbations following discharge from an emergency department. Chest. 2004;126:362–368
  33. Edmonds ML, Camargo CA, Brenner BE, Rowe BH. Replacement of oral corticosteroids with inhaled corticosteroids in the treatment of acute asthma following emergency department discharge; a meta-analysis. Chest. 2002;121:1798–1805
  34. Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA. 1999;281:2119–2126
  35. Stevens MW, Gorelick MH. Short-term outcomes after acute treatment of pediatric asthma. Pediatrics. 2001;107:1357–1362
  36. Baren JM, Shofer FS, Ivey B, et al. A randomized, controlled trial of a simple emergency department intervention to improve the rate of primary care follow-up for patients with acute asthma exacerbations. Ann Emerg Med. 2001;38:115–122
  37. Zorc JJ, Scarfone RJ, Li Y, et al. Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial. Pediatrics. 2003;111:495–502
  38. Berger WE, Legotteta AP, Blaiss MS, et al. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol. 2004;93:538–545
  39. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalisation for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin Immunol. 1996;97:742–748
  40. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887–891
  41. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107:706–711
  42. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054–1063
  43. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003;361:1071–1076
  44. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288–1293
  45. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials. Thorax. 2000;55:478–483
  46. Klingman D, Bielory L, Wang Y, et al. Asthma outcome changes associated with use of the leukotriene antagonist zafirlukast. Manag Care Interface. 2001;14:62–66
  47. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med. 1998;158:1213–1220
  48. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma (A randomized, controlled trial). Ann Intern Med. 1999;130:487–495
  49. Stempel DA, Meyer JW, Stanford RH, Yancey SW. One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma. J Allergy Clin Immunol. 2001;107:94–98
  50. Orsini L, Limpa-Amara S, Crown WH, Stanford RH, Kamal K. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast. Ann Allergy Asthma Immunol. 2004;92:523–529
  51. Stempel DA, O’Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol. 2002;109:433–439
  52. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med. 1989;320:271–277
  53. Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol. 2005;115:459–465
  54. Ferreira MAR. Inflammation in allergic asthma: initiating events, immunological response and risk factors. Respirology. 2004;9:16–24
  55. Platts-Mills TAE. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med. 2001;164:S1–S5
  56. Pollart SM, Chapman MD, Fiocco GP, et al. Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol. 1989;83:875–882
  57. Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 2005;60:302–308
  58. Corren J, Casale T, Deniz Y, Ashby M. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. J Allergy Clin Immunol. 2003;111:87–90
  59. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108:184–190
  60. Solèr M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J. 2001;18:254–261(Erratum in: Eur Respir J 2001;18:739–40)
  61. Xolair (omalizumab) for Subcutaneous Use [package insert]. South San Francisco, CA: Genentech, Inc and East Hanover, NJ: Novartis Pharmaceutical Corporation; 2003.

 Clinical Communications (Adults) is coordinated by Ron Walls, md, of Brigham and Women’s Hospital and Harvard University Medical School, Boston, Massachusetts

PII: S0736-4679(06)00632-9

doi: 10.1016/j.jemermed.2006.04.016

The Journal of Emergency Medicine
Volume 32, Issue 1 , Pages 27-39 , January 2007

Article Tools

* Image Usage & Resolution